APA-referens (7:e uppl.)

Koduru, T. S., Gupta, V. N., Veeranna, B., & Seetharaman, S. (2023). A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse. MDPI AG.

Chicago-referens (17:e uppl.)

Koduru, Trideva Sastri, Vishal N. Gupta, Balamuralidhara Veeranna, och Shanmuganathan Seetharaman. A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an MiR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse. MDPI AG, 2023.

MLA-referens (9:e uppl.)

Koduru, Trideva Sastri, et al. A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an MiR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse. MDPI AG, 2023.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.